Physician

Alida Pena Gonzalez, ARNP

According to 2025 Medicare claims, Alida Gonzalez, ARNP (NPI: 1982173845) practices nurse practitioner in the Sebring, FL market, with the plurality of this provider's patient population coming from Highlands, FL. This provider's primary affiliated billing organization is ADVENTIST HEALTH SYSTEM-SUNBELT INC (NPI: 1164698809; TIN: 590725553) and primary practice location at 33870-8226.

Gonzalez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 598 traditional Medicare patients, billed 1,638 HCPCS/CPT codes, and received $68,463 in Medicare payments. The top billing code was 0241U (Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected). Part D data shows 4,724 prescription claims across 1,005 beneficiaries totaling $258,235 in drug costs, led by Jardiance (Empagliflozin). Open Payments data shows 3 records totaling $62. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $15,002 to $68,463. Similarly, Part D prescription costs have moved sharply higher in recent years, from $20,572 to $258,235. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$34K$68K2020 Medicare payment: $15,002 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $40,443 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $53,892 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $47,078 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $68,463 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020303353$15,002
2021684838$40,443
20228821,130$53,892
20236131,069$47,078
20245981,638$68,463

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$129K$258K2020 Drug cost: $20,572 (USD; Tot_Drug_Cst)2021 Drug cost: $86,872 (USD; Tot_Drug_Cst)2022 Drug cost: $110,703 (USD; Tot_Drug_Cst)2023 Drug cost: $199,407 (USD; Tot_Drug_Cst)2024 Drug cost: $258,235 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020361766$20,572
20216931,609$86,872
20221,0202,565$110,703
20239642,877$199,407
20241,0054,724$258,235

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
0241URespiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected7980$138
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more125228$73
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more399498$52
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more108108$52
81003Automated urinalysis test88100$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JardianceEmpagliflozin251,825$35,525
OzempicSemaglutide361,164$35,211
TrulicityDulaglutide19784$26,054
MounjaroTirzepatide21644$24,230
FarxigaDapagliflozin Propanediol15840$14,619

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$62Abbott Laboratories
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alida Pena Gonzalez, ARNP?

Tedicare shows public-source Medicare data for Alida Pena Gonzalez, ARNP (NPI 1982173845), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alida Pena Gonzalez, ARNP have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alida Pena Gonzalez, ARNP?

Alida Pena Gonzalez, ARNP is linked to ADVENTIST HEALTH SYSTEM-SUNBELT INC (billing NPI 1164698809) in the available physician profile data.

Does Alida Pena Gonzalez, ARNP have Open Payments data?

Alida Pena Gonzalez, ARNP has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.